ESC Heart Failure

Article	Citations
Corrigendum	102
	81
Right ventricular strain predicts outcome in patients receiving sacubitril/valsartan: A sub‐analysis of DISCOVER‐ARNI	80
Calcium channel blockers and clinical outcomes in patients with continuous‐flow left ventricular assist devices	70
Establishing a novel model to assess exercise capacity in chronic heart failure based on stress echocardiography	68
Different activation of MAPKs and Akt/GSK3β after preload vs. afterload elevation	65
Systolic dysfunction and mortality in critically ill patients: more data are needed to believe in this association!	61
Outcomes with sacubitril/valsartan in outpatients with heart failure and reduced ejection fraction: The ARIADNE registry	55
Serum angiotensin‐converting enzyme levels indicating early sarcoidosis diagnosis and immunosuppressive therapy efficacy	54
Blood perfusion status is important in the prognosis of ventricular aneurysm complicated by ventricular septal rupture	51
Editors' highlight picks from 2023 in ESC heart failure	48
Characteristics and management of very elderly patients with heart failure: a retrospective, population cohort study	47
Issue Information	45
Burden of hospitalizations in newly diagnosed heart failure patients in Poland: real world population based study in years 2013–2019	45
Cardiogenic shock requiring VA‐ECMO therapy in scorpionism‐induced myocarditis	44
Intense optimization of oral therapy rapidly restores respiratory function in worsening heart failure patients	43
Uncovering the genetic links of SARS‐CoV‐2 infections on heart failure co‐morbidity by a systems biology approach	42
Use of sodium glucose co‐transporter 2 inhibitors in acute heart failure: a practical guidance	42
Predictive value of global longitudinal strain by left ventricular ejection fraction	42
Integrated care for older multimorbid heart failure patients: protocol for the ESCAPE randomized trial and cohort study	41
Assessing the link of malnutrition with diabetes and mortality risk in heart failure patients	41
Global differences in acute heart failure treatment: analysis of the STRONG‐HF site feasibility questionnaire	41
Oral milrinone for management of refractory right ventricular failure in patients with left ventricular assist devices	41
Analysis of the serum levels of RIP3 and Drp1 in patients with heart failure	41
Risk classification for long‐term mortality among patients with acute heart failure: China PEACE 4YMortality	40

	39
Explainable machine learning and online calculators to predict heart failure mortality in intensive care units	38
Oral iron supplementation in patients with heart failure: a systematic review and meta‐analysis	38
Early achievement of walkability after cardiac surgery and the risk of cardiovascular disease after hospital discharge	38
Meta‐Analysis Global Group in Chronic Heart Failure score for the prediction of mortality in valvular heart disease	38
Synchronized diaphragmatic stimulation: a case report of a novel extra‐cardiac intervention for chronic heart failure	37
Transcatheter aortic valve replacement in aortic stenosis and cardiac amyloidosis: a systematic review and meta‐analysis	36
Reductions in renin‐angiotensin system inhibitors following hospitalization for heart failure	36
Sex differences in the impact of frailty on patients with heart failure: A retrospective cohort study	36
Cardiac involvement in patients recovering from Delta Variant of COVID‐19: a prospective multi‐parametric MRI study	36
Use of liver stiffness measurements in acute decompensated heart failure: new applications of a non‐invasive technique	36
Real‐time pulmonary artery pressure monitoring in heart failure patients: an updated cost‐effectiveness analysis	35
Prognostic value of hypoxaemic burden from overnight oximetry in heart failure with preserved ejection fraction	35
Fibroblast growth factor 23 independently predicts adverse outcomes after an acute coronary syndrome	35
Clinical course of patients with hypertrophic cardiomyopathy away from tertiary referral care	34
Health‐related quality of life among transthyretin amyloid cardiomyopathy patients	34
New insight: particle flow rate from the airways as an indicator of cardiac failure in the intensive care unit	34
Predicting cardiovascular events with fluoropyrimidine chemotherapy using a standard cardiovascular risk calculator	33
Percutaneous endocardial alginate–hydrogel injection in the treatment of heart failure: First‐in‐human study	32
Acylation‐stimulating protein and heart failure progression in arrhythmogenic right ventricular cardiomyopathy	32
Impact of early intensive GDMT on LVEF recovery and ICD decision making in de novo HFrEF	32
Biomarker profiles in heart failure with preserved vs. reduced ejection fraction: results from the DIAST‐CHF study	32
Prevalence of transthyretin amyloidosis among heart failure patients with preserved ejection fraction in Japan	32
Effect of beta‐blockade on mortality in patients with cardiac amyloidosis: A systematic review and meta‐analysis	32
Increased acylcarnitines in infant heart failure indicate fatty acid oxidation inhibition: towards therapeutic options?	31
Long‐term outcomes of electrical storm patients listed for urgent heart transplantation but not transplanted acutely	31
Atrial fibrillation ablation in patients with arrhythmia‐induced cardiomyopathy: a prospective multicentre study	31
Heart failure and trimethylamine N‐oxide: time to transform a ‘gut feeling’ in a fact?	30
Systemic immune‐inflammation index as a prognostic marker for advanced chronic heart failure with renal dysfunction	30
Impact of age on characteristics, performance measures and outcomes of inpatients for heart failure in Beijing, China	30
Clinical characteristics and frailty status in heart failure with preserved vs. reduced ejection fraction	30
Prognostic value of left atrial strain in acute and chronic heart failure: A meta‐analysis	30
Circ_0001206 regulates miR‐665/CRKL axis to alleviate hypoxia/reoxygenation‐induced cardiomyocyte injury in myocardial infarction	29
The use of MitraClip for nonobstructive hypertrophic cardiomyopathy with mixed severe mitral valve regurgitation	29
Meta‐analysis of cardiac magnetic resonance in prognosticating left ventricular function in peripartum cardiomyopathy	29
Prognostic value of left atrial reverse remodelling in patients hospitalized with acute decompensated heart failure	28
Platelet count in heart failure patients undergoing left ventricular assist device	28
Issue Information	28
Angiographic classification of total occlusion and its implication on balloon pulmonary angioplasty	28
Achieved dose and treatment discontinuation of candesartan in men and women with chronic heart failure: data from CHARM	28
Left ventricular reverse remodelling as a promising strategy for resolving left ventricular thrombus	28
Acute myocarditis according to age: Presentation, management and early outcomes	27
Sex‐specific associations of cardiorespiratory fitness and galectin‐3 in the general population	27
Correction to “Understanding the variability in red cell and plasma volume combinations can help guide management in heart failure”	27
Letter to the editor regarding ‘Autopsy findings in cases of fatal COVID‐19 vaccine‐induced myocarditis’	27
Effects of homoarginine supplementation on heart and skeletal muscle of rats with heart failure with preserved ejection fraction	26
Gender‐specific prevalence and trend of heart failure in China from 1990 to 2019	26
Rationale and design of the Biventricular Evaluation of Gliflozins effects In chroNic Heart Failure: BEGIN‐HF study	26
Adrenomedullin peptides and precursor levels in relation to haemodynamics and prognosis after heart transplantation	26
Cost‐utility analysis of add‐on Qili Qiangxin capsules in chronic heart failure with reduced ejection fraction in China	26

Human epididymis protein 4 is a useful predictor of post‐operative prognosis in patients with severe aortic stenosis	25
Clinical impact of follow‐up endomyocardial biopsy in myocarditis during or after immune‐suppressive therapy	25
Transthyretin amyloid cardiomyopathy in aortic stenosis patients scheduled for transcatheter aortic valve implantation	24
Incident heart failure: comparing management and outcome in primary and hospital settings in Western Sweden 2008–2017	24
Proteins associated with rehospitalization, mortality and diuretic resistance in acutely decompensated heart failure	24
Identification of molecular signatures in epicardial adipose tissue in heart failure with preserved ejection fraction	24
Dapagliflozin reduces pulmonary vascular damage and susceptibility to atrial fibrillation in right heart disease	24
Prognostic value of Growth differentiation factors 15 in Acute heart failure patients with preserved ejection fraction	24
Importance of non‐cardiovascular comorbidities in atrial fibrillation and heart failure with preserved ejection fraction	24
Effects of exercise modalities on physical function and quality of life in patients with heart failure: A systematic review and network meta‐analysis	24
Outcomes after heart transplantation in patients with cardiac sarcoidosis	24
Lean ZSF1 rats in basic research on heart failure with preserved ejection fraction	23
Higher BNP/NT‐pro BNP levels stratify prognosis equally well in patients with and without heart failure: a meta‐analysis	23
Advances in device‐based treatment of heart failure with preserved ejection fraction: evidence from clinical trials	23
Association of BMI with adherence and outcome in heart failure patients treated with wearable cardioverter defibrillator	23
Trimetazidine in heart failure with preserved ejection fraction: a randomized controlled cross‐over trial	23
Validation of heart failure algorithm for diagnosing heart failure with preserved ejection fraction: a meta‐analysis	23
Time‐domain heart rate variability features for automatic congestive heart failure prediction	22
Digital health in older adults for the prevention and management of cardiovascular diseases and frailty. A clinical consensus statement from the ESC Council for Cardiology Practice/Taskforce on Ger	22
Congestion, decongestion, renal function and diuretics in (ESC) heart failure	22
Simultaneous vaccination against influenza and respiratory syncytial virus in high‐risk heart failure patients	22
Differences between cardiogenic shock related to acute decompensated heart failure and acute myocardial infarction	22
SARS‐CoV‐2‐related Multisystem Inflammatory Syndrome in Adult complicated by myocarditis and cardiogenic shock	22
Letter to the editor: Soluble urokinase plasminogen activator receptor and outcomes in HFpEF: A TOPCAT ancillary study	22
A prospective analysis of management and outcomes of worsening heart failure in the outpatient setting	22
Delay in cardiology consultation after primary care physician referrals in heart failure: Clinical implications	21
Soluble neprilysin and survival in critically ill patients	21
Takotsubo cardiomyopathy during armed conflict: A case series	21
Vericiguat and NT‐proBNP in patients with heart failure with reduced ejection fraction: analyses from the VICTORIA trial	21
Adaptive versus maladaptive right ventricular remodelling	21
Regional expert opinion: Management of heart failure with preserved ejection fraction in the Middle East, North Africa and Turkey	21
Long‐term mortality in heart failure with mid‐range ejection fraction: systematic review and meta‐analysis	20
Sex‐based differences in referral of heart failure patients to outpatient clinics: a scoping review	20
Clinical application and immune infiltration landscape of stemness‐related genes in heart failure	20
Corrigendum	20
Role of vericiguat in management of patients with heart failure with reduced ejection fraction after worsening episode	20
Plasma volume status predicting clinical outcomes in patients undergoing transcatheter edge‐to‐edge mitral valve repair	20
Biomarker prognostication across Universal Definition of Heart Failure stages	20
Letter regarding the article “Hypocapnia is an independent predictor of in‐hospital mortality in acute heart failure”	20
The impact of heart failure therapy in patients with mildly reduced ejection fraction: a network meta‐analysis	20
Severe aortic insufficiency‐induced cardiogenic shock treated with left atrial VA‐ECMO and emergent valve‐in‐valve TAVR	20
A contemporary simple risk score for prediction of severe acute kidney injury after heart transplantation	20
Genotype is associated with left ventricular reverse remodelling and early events in recent‐onset dilated cardiomyopathy	20
Considerations for drug trials in hypertrophic cardiomyopathy	19
Tyrosine to threonine ratio was related to heart failure with reduced or mildly reduced ejection fraction	19
Biomarkers in heart failure: Traditional and emerging indicators for prognosis	19
Prognostic impact of a history of cancer and atrial fibrillation in antithrombotic therapy for chronic heart failure	19
Predicted impact of atrial flow regulator on survival in heart failure with reduced and preserved ejection fraction	19
A polygenic risk score of atrial fibrillation improves prediction of lifetime risk for heart failure	19
Novel electrocardiographic criteria may render possible the more accurate recognition of cardiac amyloidosis	19
Cognitive transitions based on functional status in older adults with heart failure: a population‐based study	19
Response to Letter to the editor regarding ‘Discordance between estimated and measured changes in plasma volume among patients with acute heart failure’	19
Effects of door‐to‐tolvaptan time on short‐term clinical outcome in patients with acute heart failure	19
Smartwatches in the assessment of heart failure patients in epidemiology and pathophysiology studies: A scoping review	19
Baroreflex activation therapy in patients with heart failure with reduced ejection fraction: a single‐centre experience	19
Impact of cardiac resynchronization therapy optimization inside a heart failure programme: a real‐world experience	19
Temporal profiling of M‐TEER‐related complications	19
Prognostic impact of heart failure admission in survivors of acute myocardial infarction	19
Investigating the relationship between FRailty And Quality of LIfe in patients with heart faiLure and CKD (FRAIL study)	19
Pre‐emptive treatment of heart failure exacerbations in patients managed with the HeartLogic™ algorithm	19
Early diagnosis, disease stage and prognosis in wild‐type transthyretin amyloid cardiomyopathy: The DIAMOND study	18
Long‐term prognosis of pure and impure tachycardiomyopathy	18
The efficacy and safety of sodium‐glucose cotransporter 2 inhibitors in patients aged over 80 years with heart failure	18
Narrative synthesis of the effectiveness and characteristics of heart failure disease self‐management support programmes	18
A meta‐analysis of the relationship between glycaemic variability and the mortality of patients with heart failure	18
Novel mutation associated with non‐compaction ventricular myocardium: A case report	18
Efficacy and safety of digital therapeutics‐based cardiac rehabilitation in heart failure patients: a systematic review	18
Incidence, mortality, and predictors of acute kidney injury in patients with heart failure: a systematic review	18
Five‐year mortality of heart failure with preserved, mildly reduced, and reduced ejection fraction in a 4880 Chinese cohort	18
Real‐world effectiveness of targeted therapies in ATTR cardiomyopathy: A meta‐analysis integrating population‐based data	18
E prostanoid receptor‐3 promotes oxidized low‐density lipoprotein‐induced human aortic smooth muscle cells inflammation	18
Diagnostic and prognostic value of the left atrial myopathy evaluation in cardiac amyloidosis using echocardiography	18
Clinical performance and quality measures for heart failure management in China: the China‐Heart Failure registry study	18
Eniluracil blocks AREG signalling‐induced pro‐inflammatory fibroblasts of melanoma in heart failure	17
Comprehensive exploration of unexplained dyspnoea in subjects with normal ejection fraction and low natriuretic peptides	17
Six‐months immunogenicity of BNT162b2 mRNA vaccine in heart transplanted and ventricle assist device‐supported patients	17
Sodium‐glucose transporter 2 inhibitors may improve the prognosis of acute heart failure by correcting hypocapnia	17
Cardiovascular vs. non‐cardiovascular deaths after heart failure hospitalization in young, older, and very old patients	17
The characteristic large‐scale annual analysis by gender and age in heart failure patients: cohort for 10 years in Korea	17
Analysis of the usefulness and benefits of ultrafiltration in cardiorenal syndrome: A systematic review	17

Atrial‐secondary tricuspid regurgitation: a better prognosis in early stage heart failure, but not in late stage	17
Prognostic implications of functional tricuspid regurgitation in asymptomatic degenerative mitral regurgitation	17
Serum a‐1 antitrypsin as a novel biomarker in chronic heart failure	17
Myocarditis following rAd26 and rAd5 vector‐based COVID‐19 vaccine: correspondence	17
IgM‐enriched immunoglobulin as adjuvant therapy for heart transplant after infection of left ventricular assist devices	17
Changes over time in patient‐reported outcomes in patients with heart failure	17
Letter to the editor regarding ‘Discordance between estimated and measured changes in plasma volume among patients with acute heart failure’	17
Dose titration of sacubitril/valsartan for heart failure with reduced ejection fraction: a real‐world study	17
Interpretation of elevated baseline concentrations and serial changes of high‐sensitivity cardiac troponin T in confirmed muscular dystrophies	17
The association between cardiac involvement and long‐term clinical outcomes in patients with Duchenne muscular dystrophy	17
Multiorgan characterization of inflammasome component expression in a rat model of advanced heart failure	17
Relationship between haemodynamic indicators and haemogram in patients with heart failure	17
Correction to: “Obesity and contraceptive use: impact on cardiovascular risk”	17
Impact of B‐lines‐guided intensive heart failure management on outcome of discharged heart failure patients with residual B‐lines	17
Body mass index, frailty, and outcomes in heart failure with preserved ejection fraction	17
A nationwide study of temporal trends of cause‐specific hospital readmissions in patients with heart failure	17
Issue Information	17
Impact of the COVID‐19 pandemic on management and outcomes of patients with acute heart failure	17
Estimated pulse wave velocity and risk of new‐onset heart failure	16
Issue Information	16
Paediatric heart transplantation during the COVID‐19 pandemic in Iran: single‐centre experience	16
Serum glial fibrillary acidic protein indicates memory impairment in patients with chronic heart failure	16
Systematic review of sodium‐glucose cotransporter 2 inhibitors: a hopeful prospect in tackling heart failure‐related events	16
Alcohol septal ablation in hypertrophic cardiomyopathy: For which patients?	16
Issue Information	16
Sodium‐glucose cotransporter‐2 inhibitors in heart failure: an updated meta‐analysis	16
Hyperkalaemia as a cause of undertreatment with mineralocorticoid receptor antagonists in heart failure	16
Trametinib alters contractility of paediatric Noonan syndrome‐associated hypertrophic myocardial tissue slices	16
Relationship of atrial fibrillation and N terminal pro brain natriuretic peptide in heart failure patients	16
Improved mortality and haemodynamics with milrinone in cardiogenic shock due to acute decompensated heart failure	16
Safety and efficacy of MitraClip in acutely ill (NYHA Class IV) patients with mitral regurgitation: Results from the global EXPAND study	16
Effect of early intervention on short‐term prognosis of patients with myocardial injury induced by acute carbon monoxide poisoning	16
Is ischaemic heart failure an autoimmune disease?	16
Baseline kidney function and the effects of dapagliflozin on health status in heart failure in DEFINE‐HF and PRESERVED‐HF	16
Clinical characteristics, outcome, and therapeutic effect of tafamidis in wild‐type transthyretin amyloid cardiomyopathy	15
Characterization of critically ill patients with septic shock and sepsis‐associated cardiomyopathy using cardiovascular MRI	15
Application of recommended therapies among patients with heart failure during the Syrian conflict: reality and barriers	15
ST‐segment depression and left ventricular systolic function recovery post‐atrial fibrillation ablation in heart failure	15
Non‐dilated left ventricular cardiomyopathy vs. dilated cardiomyopathy: clinical background and outcomes	15
Integrin beta‐like 1 is regulated by DNA methylation and increased in heart failure patients	15
Advanced heart failure: guideline‐directed medical therapy, diuretics, inotropes, and palliative care	15
Utilizing longitudinal data in assessing all‐cause mortality in patients hospitalized with heart failure	15
Early detection of anthracycline‐ and trastuzumab‐induced cardiotoxicity: value and optimal timing of serum biomarkers and echocardiographic parameters	15
Correction to “Impact analysis of heart failure across European countries: an ESC‐HFA position paper” and “Echocardiographically defined haemodynamic categorization predicts prognosis in ambulatory he	15
A simple staging system using biomarkers for wild‐type transthyretin amyloid cardiomyopathy in Japan	15
Transition from asymptomatic to symptomatic systolic chronic heart failure: rationale and design of TransitionCHF	15
Egyptian expert opinion for the use of sodium‐glucose cotransporter‐2 inhibitors in patients with heart failure with reduced ejection fraction	15
A case of biopsy‐proven inflammatory dilated cardiomyopathy following heterologous mRNA‐1273 third‐dose immunization	15
S2I2N0–3 score predicts short‐ and long‐term mortality and morbidity in HFrEF: a post‐hoc analysis of the GUIDE‐IT trial	15
Susceptibility to infections and adaptive immunity in adults with heart failure	15
Mavacamten in real‐life practice: Initial experience at a hypertrophic cardiomyopathy centre	15
Effects of bariatric surgery on cardiovascular‐related acute care use in patients with hypertrophic cardiomyopathy	15
Therapy gaps for patients with heart failure and reduced kidney function: A prospective cohort study	15
Clinical profile and 90 day outcomes of 10 851 heart failure patients across India: National Heart Failure Registry	15
Corticosteroid burst therapy in patients with acute heart failure: Design of the CORTAHF pilot study	15
Associations between in‐hospital daily protein intake and adverse clinical outcomes in older patients with heart failure	15
Cardiac arrest caused by coronary occlusion during transcatheter aortic valve implantation: a unique cause	15
Fractional excretion of urea nitrogen can identify true worsening renal function in patients with heart failure	15
Diuretic dose is a strong prognostic factor in ambulatory patients awaiting heart transplantation	15
The HFA‐PEFF score identifies ‘early‐HFpEF’ phenogroups associated with distinct biomarker profiles	15
Low‐density lipoprotein cholesterol, erythrocyte, and platelet in heart failure with preserved ejection fraction	15
Pressure–strain loops unveil haemodynamics behind mechanical circulatory support systems	14
U‐shaped association between body mass index and ejection fraction in intensive care unit patients with heart failure	14
Prognostic effect of systematic geriatric assessment on patients with acute heart failure	14
Construction of a web‐based dynamic nomogram for predicting the prognosis in acute heart failure	14
Increased calcification by erythrophagocytosis in aortic valvular interstitial cells	14
Frailty alone and interactively with obesity predicts heart failure: Kuopio Ischaemic Heart Disease Risk Factor Study	14
Long term changes in health‐related quality of life for people with heart failure: the ECHOES study	14
The double anaerobic threshold in heart failure: MECKI score database overview	14
Two‐year outcome of ventricular assist device via a modified left atrium to aorta approach in cardiac amyloidosis	14
Predicting 1‐year heart failure hospitalization and mortality post‐discharge from the intensive cardiac care unit	14
Ten year age‐ and sex‐specific temporal trends in incidence and prevalence of heart failure in Västra Götaland, Sweden	14
Prognostic impact of beta‐blocker use by N‐terminal pro‐brain natriuretic peptide level in acute heart failure patients	14
Association between central haemodynamics and renal function in advanced heart failure: a nationwide study from Sweden	14
Prognostic value of high‐sensitivity cardiac troponin I in patients with non‐ischaemic heart failure: insights from China	14
Efficacy of catheter ablation for atrial fibrillation in heart failure: a meta‐analysis of randomized controlled trials	14
Pre‐admission beta‐blocker therapy and outcomes in cardiogenic shock: Insights from the Altshock‐2 Registry	14
Multidisciplinary care: A missing solution to SGLT2 inhibitor underuse in heart failure	14
The favourable alliance between CardioMEMS and levosimendan in patients with advanced heart failure	14
In vivo fluid dynamics of the Ventura interatrial shunt device in patients with heart failure	14
Initial experience with transcatheter tricuspid valve repair in patients with cardiac amyloidosis	14
Dramatic disease regression in a case of HFrEF with end‐stage renal failure treated with sacubitril/valsartan and SGLT2i	14
Association between trimethylamine N‐oxide and prognosis of patients with acute myocardial infarction and heart failure	14
Neutrophil‐to‐lymphocyte ratio: link to congestion, inflammation, and mortality in outpatients with heart failure	14
Decoding cardiogenic shock: assessing shock index and its variants as prognostic indicators for in‐hospital mortality	14
Spontaneous coronary hematoma concomitant with myocarditis: the first report of double cardiac complication of dengue	13
First‐in‐human experience of preload regulation with percutaneous transluminal caval flow regulation in heart failure with reduced ejection fraction patients	13
Haemodynamic changes of interatrial shunting devices for heart failure: a systematic review and meta‐analysis	13
Association of plasma metabolites and cardiac mitochondrial function with heart failure progression	13
The novel proteomic signature for cardiac allograft vasculopathy	13
Prognostic impact of plasma volume status during hospital admission in patients with acute decompensated heart failure	13
Issue Information	13
	13
Risk prediction of mortality for patients with heart failure in England: observational study in primary care	13
Transjugular tricuspid valve‐in‐ring replacement using the novel system under three‐dimensional printing guidance	13